[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Embecta Corp (EMBC)

Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 296,047
  • Shares Outstanding, K 59,328
  • Annual Sales, $ 1,080 M
  • Annual Income, $ 95,400 K
  • EBIT $ 224 M
  • EBITDA $ 284 M
  • 60-Month Beta 0.81
  • Price/Sales 0.24
  • Price/Cash Flow 1.10
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 120.26% (+45.22%)
  • Historical Volatility 87.42%
  • IV Percentile 80%
  • IV Rank 48.30%
  • IV High 202.64% on 05/15/26
  • IV Low 43.29% on 08/29/25
  • Expected Move (DTE 10) 0.35 (7.14%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 920
  • Volume Avg (30-Day) 348
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 8,343
  • Open Int (30-Day) 6,561
  • Expected Range 4.53 to 5.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.31
  • Number of Estimates 1
  • High Estimate $0.31
  • Low Estimate $0.31
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -38.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.07 +58.96%
on 07/14/26
5.14 -5.06%
on 08/11/26
+1.64 (+50.62%)
since 07/10/26
3-Month
2.77 +76.17%
on 05/20/26
5.14 -5.06%
on 08/11/26
+1.52 (+45.24%)
since 05/11/26
52-Week
2.77 +76.17%
on 05/20/26
15.55 -68.62%
on 09/17/25
-7.85 (-61.67%)
since 08/11/25

Most Recent Stories

More News
Kaplan Fox Encourages Embecta Corp. (NASDAQ: EMBC) Investors to Contact the Firm Before the Deadline on August 17, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

EMBC : 4.88 (-2.20%)
Kaplan Fox Encourages Embecta Corp. (NASDAQ: EMBC) Investors to Contact the Firm Before the Lead Plaintiff Deadline on August 17, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

EMBC : 4.88 (-2.20%)
EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop

A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its...

EMBC : 4.88 (-2.20%)
Embecta Corp. Notice of August 17, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

SAN FRANCISCO , Aug. 11, 2026 /PRNewswire/ -- Hagens Berman, a leading national shareholder rights law firm, is conducting an investigation into Embecta Corp. ( NASDAQ: EMBC ) regarding ...

EMBC : 4.88 (-2.20%)
Kaplan Fox Encourages Investors of Embecta Corp. (NASDAQ: EMBC) to Contact the Firm Before Lead Plaintiff Deadline on August 17, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

EMBC : 4.88 (-2.20%)
EMBC INVESTOR ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN FRANCISCO , Aug. 10, 2026 /PRNewswire/ -- Hagens Berman, a leading national shareholder rights law firm, is conducting an investigation into Embecta Corp. ( NASDAQ: EMBC ) regarding alleged...

EMBC : 4.88 (-2.20%)
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law

LOS ANGELES , Aug. 10, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP  ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta...

EMBC : 4.88 (-2.20%)
Embecta Corp. Notice of August 17, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

SAN FRANCISCO , Aug. 9, 2026 /PRNewswire/ -- Hagens Berman, a leading national shareholder rights law firm, is conducting an investigation into Embecta Corp. ( NASDAQ: EMBC ) regarding alleged...

EMBC : 4.88 (-2.20%)
EMBC Deadline: EMBC Investors with Losses in Excess of $100K Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

NEW YORK , Aug. 7, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4,...

EMBC : 4.88 (-2.20%)
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

PARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...

EMBC : 4.88 (-2.20%)

Business Summary

Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.

See More

Key Turning Points

3rd Resistance Point 5.36
2nd Resistance Point 5.25
1st Resistance Point 5.07
Last Price 4.88
1st Support Level 4.77
2nd Support Level 4.66
3rd Support Level 4.47

See More

52-Week High 15.55
Fibonacci 61.8% 10.67
Fibonacci 50% 9.16
Fibonacci 38.2% 7.65
Last Price 4.88
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.